UP-03.25
October 2006
in “
Urology
”
TLDR Finasteride may help treat BPH by affecting certain biological markers.
The study investigated the effects of finasteride on the expression of hypoxia-inducible factor (HIF-1a) and vascular endothelial growth factor (VEGF) in benign prostatic hyperplasia (BPH). The research aimed to assess how finasteride, a medication commonly used to treat BPH, influenced these angiogenetic and hypoxia markers. The findings provided insights into the biological mechanisms through which finasteride may exert its therapeutic effects in BPH, although specific results and the number of participants involved in the study were not detailed in the document.